AstraZeneca PLC (AZN) vs Humana Inc. (HUM)
AZN leads on 14 of 16 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs HUM
growth of $100 · last 30yAZN +723.4%HUM +1977.9%HUM compounded faster
AZN HUM
AZN vs HUM: by the numbers
- •AZN is the larger company ($277.22B vs $45.53B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 40.56 P/E).
- •AZN converts more revenue to profit (17.19% vs 0.82% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 11.71% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 0.93%).
Which is better, AZN or HUM?
Metric tally: AZN 14 · HUM 2It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Valuation
| Metric | AZN | HUM |
|---|---|---|
| P/E ratio | 26.92● | 40.56 |
| Forward P/E | 15.33● | 23.94 |
| P/S ratio | 4.62 | 0.33● |
| P/B ratio | 5.90 | 2.46● |
| PEG ratio | 0.14 | — |
| EV / EBITDA | 14.92● | 19.22 |
| FCF yield | 3.26%● | 2.78% |
Profitability
| Metric | AZN | HUM |
|---|---|---|
| Gross margin | 81.68%● | 14.01% |
| Operating margin | 23.69%● | 1.01% |
| Net margin | 17.19%● | 0.82% |
| ROE | 21.95%● | 6.08% |
| ROIC | 13.03%● | 3.12% |
Dividends
| Metric | AZN | HUM |
|---|---|---|
| Dividend yield | 1.79%● | 0.93% |
| Payout ratio | 48.48% | 35.87% |
Growth (annualized)
| Metric | AZN | HUM |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 11.71% |
| EPS CAGR (5Y) | 22.02%● | -17.27% |
| FCF CAGR (5Y) | 18.52%● | -17.19% |
| Total return CAGR (5Y) | 11.03%● | -1.01% |
Frequently asked
- Which is better, AZN or HUM?
- It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 14 to 2.
- Is AZN or HUM cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and HUM at 40.56.
- Which has grown faster, AZN or HUM?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus HUM at 11.71%.
- Does AZN or HUM pay a bigger dividend?
- AZN yields 1.79% and HUM yields 0.93% based on trailing dividends and the latest price.
- Is AZN or HUM more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus HUM at 0.82%.
- Which has been the better investment, AZN or HUM?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus HUM at 8.24%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioHumana P/E ratioAstraZeneca dividend yieldHumana dividend yieldAstraZeneca ROEHumana ROEAstraZeneca operating marginHumana operating marginAstraZeneca revenue growthHumana revenue growthAstraZeneca free cash flowHumana free cash flow
AstraZeneca & Humana appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.